To TRIM the Immunity: From Innate to Adaptive Immunity

Wenyong Yang(Sichuan University), Hongbo Hu(The University of Texas MD Anderson Cancer Center), Huiyuan Zhang(Baylor College of Medicine), Zhiwen Gu(Shanghai Institute of Materia Medica)
Frontiers in Immunology
October 8, 2020
10.3389/fimmu.2020.02157
Cited by 83

Related Papers

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
|Signal Transduction and Targeted Therapy|2020|2k
STAT3 controls myeloid progenitor growth during emergency granulopoiesis
|Blood|2010|227
Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination
|The Journal of Experimental Medicine|2016|106
Resveratrol Inhibits Enterovirus 71 Replication and Pro-Inflammatory Cytokine Secretion in Rhabdosarcoma Cells through Blocking IKKs/NF-κB Signaling Pathway
|PLoS ONE|2015|73
mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling
|APOPTOSIS|2014|49